title: In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity.
authors.forename: M
authors.initials: M
authors.lastname: Martín
authors.forename: L
authors.initials: L
authors.lastname: Aguilar
authors.forename: I P
authors.initials: IP
authors.lastname: Balcabao
authors.forename: M L
authors.initials: ML
authors.lastname: Gómez-Lus
authors.forename: R
authors.initials: R
authors.lastname: Dal-Ré
authors.forename: J
authors.initials: J
authors.lastname: Prieto
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000097:blood / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000201:enzymology; D065093:beta-Lactamase Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004791:Enzyme Inhibitors; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid